삼성서울병원

Ko En

Radiation Oncology Ahn, Yong Chan M.D

Expertise
Head and neck cancer, lung cancer, stereotactic ablative radiation therapy, proton beam therapy
Treament Schedule 05 月
DATE
THU
01
FRI
02
SAT
03
SUN
04
MON
05
TUE
06
WEB
07
THU
08
FRI
09
SAT
10
SUN
11
MON
12
TUE
13
WEB
14
THU
15
FRI
16
SAT
17
SUN
18
MON
19
TUE
20
WEB
21
THU
22
FRI
23
SAT
24
SUN
25
MON
26
TUE
27
WEB
28
THU
29
FRI
30
SAT
31
AM
PM
Treament Schedule 06 月
DATE
SUN
01
MON
02
TUE
03
WEB
04
THU
05
FRI
06
SAT
07
SUN
08
MON
09
TUE
10
WEB
11
THU
12
FRI
13
SAT
14
SUN
15
MON
16
TUE
17
WEB
18
THU
19
FRI
20
SAT
21
SUN
22
MON
23
TUE
24
WEB
25
THU
26
FRI
27
SAT
28
SUN
29
MON
30
AM
PM

Medical Education

1996~2003 Ph.D. in Medicine Graduate College of Medicne, Seoul National University, Korea
1990~1992 Master of Medical Science Graduate College of Medicne, Seoul National University, Korea
1978~1984 Medical Doctor College of Medicine, Seoul National University, Korea

Post-Graduate Training

Fellowship   1993~1994 Department of Radiation Oncology, British Columbia Cancer Agency, BC, Canada
1992~1993 Department of Radiation Medicine, Roswell Park Cancer Institute, NY, USA
Residency   1989~1992 Department of Radiation Oncology, Seoul National University Hospital, Korea
Internship   1984~1985 Seoul National University Hospital, Korea

Professional Appointments

2014~2016 Vice-Dean Sungkyunkwan Univeristy School of Medicine
2009~Present Professor Department of Radiation Oncology, Sungkyunkwan Univeristy School of Medicine
2005~2009 Chairman Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan Univeristy School of Medicine
2003~2009 Associate Professor Department of Radiation Oncology, Sungkyunkwan Univeristy School of Medicine
1997~2003 Assistant Professor Department of Radiation Oncology, Sungkyunkwan Univeristy School of Medicine
1994~Present Staff Radiation Oncologist Department of Radiation Oncology, Samsung Medical Center, Korea

Professional Memberships

Domestic:
2001. 01 ~ Director, The Korean Lung Cancer Study Group
2004. 07 ~ Director, Korean Cancer Association
2004. 10 ~ 2007. 09: Director of General Affairs and Treasury, Korean Society for Therapeutic Radiology and Oncology
2007. 10 ~ Director of Board Qualifying Examination, Korean Society for Therapeutic Radiology and Oncology
2008. 10 ~ Vice-Editor-in-Chief, Korean Cancer Association
2008. 11 ~ Director of Public Relation, Korean Society for Head & Neck Oncology

International Membership:
American Society for Therapeutic Radiology and Oncology (ASTRO)
European Society for Therapeutic Radiology and Oncology (ESTRO)

Selected Publications

  • CANCERS 2025 10.3390/cancers17030554 Salivary Gland Volume Changes and Dry Mouth Symptom Following Definitive Radiation Therapy in Oropharyngeal Cancer Patients-A Comparison of Two Different Approaches: Intensity-Modulated Radiation Therapy Versus Intensity-Modulated Radiation Therapy/Intensity-Modulated Proton Therapy Combination Park, SG; Ahn, YC; Oh, D; Yang, K; Ju, SG; Kim, JM; Kwon, D; Choi, E; Yoon, HG
    View PubMed
  • CANCER RES TREAT 2025 10.4143/crt.2024.688 Identifying Trends in Oncology Research through a Bibliographic Analysis Cancer Research and Treatment Lee, CK; Choo, JM; Ahn, YC; Kim, J; Rha, SY; Rim, CH; Korean Canc Assoc
    View PubMed
  • CANCER RES TREAT 2025 10.4143/crt.2024.191 Salvage Radiotherapy for Loco-regional Recurrence of Esophageal Cancer Following Surgery Cho, WK; Noh, JM; Oh, D; Ahn, YC; Sun, JM; Kim, HK; Shim, YM
    View PubMed
  • INT J RADIAT ONCOL 2024 10.1016/j.ijrobp.2024.07.2143 International Recommendations on Postoperative Management for Potentially Resectable Locally Recurrent Nasopharyngeal Carcinoma Li, JS; Blanchard, P; Wong, CHL; Ahn, YC; Bonomo, P; Bresson, D; Caudell, J; Chen, MY; Chow, VLY; Chua, MLK; Franzcr, JC; Dupin, C; Giralt, J; Hu, CS; Kwong, DLW; Le, QT; Lee, AWM; Lee, NY; Li, YZ; Lim, CM; Lin, JC; Mendenhall, WM; Moya-Plana, A; O'Sullivan, B; Ozyar, E; Pan, JJ; Qiu, QH; Sher, DJ; Snyderman, CH; Tao, YG; Tsang, RK; Wang, XS; Wu, PA; Yom, SS; Ng, WT
    View PubMed
  • ONCOLOGY-BASEL 2024 10.1159/000543281 Adjuvant Sequential Chemotherapy for Salivary Duct Carcinomas: A Retrospective Comparative Analysis Kim, Y; Choi, N; Kim, EH; Chung, MK; Son, YI; Oh, D; Ahn, YC; Lee, SH; Jung, HA; Park, S; Kim, J; Jeong, HS; Ahn, MJ
    View PubMed
  • EUR J CANCER 2024 10.1016/j.ejca.2024.115043 A new proposal of simplified classification of non-small cell lung cancer oligometastases for easy applicability through systematic literature analysis and meta-analysis validation Kang, HS; Do, W; Ahn, YC; Chie, EK; Rim, CH
    View PubMed
  • CANCER RES TREAT 2024 10.4143/crt.2024.084 Adjuvant Pembrolizumab in Patients with Stage IIIA/N2 Non-Small Cell Lung Cancer Completely Resected after Neoadjuvant Concurrent Chemoradiation: A Prospective, Open-Label, Single-Arm, Phase 2 Trial Shin, J; Park, S; Kim, KH; Shin, EC; Jung, HA; Cho, JH; Sun, JM; Lee, SH; Choi, YS; Ahn, JS; Kim, J; Park, K; Shim, YM; Kim, HK; Noh, JM; Ahn, YC; Pyo, H; Ahn, MJ
    View PubMed
  • CANCERS 2024 10.3390/cancers16193402 Dosimetric Comparison and Selection Criteria of Intensity-Modulated Proton Therapy and Intensity-Modulated Radiation Therapy for Adaptive Re-Plan in T3-4 Nasopharynx Cancer Patients Ko, M; Yang, K; Ahn, YC; Ju, SG; Oh, D; Kim, YB; Kwon, DY; Park, S; Lee, K
    View PubMed
  • CANCERS 2024 10.3390/cancers16142554 Surgical Interventions Following Radiotherapy in Spinal Metastases with Intermediate Instability: A Risk Factor Analysis: The Korean Society of Spinal Tumor Multicenter Study (KSST 2022-02) Park, SJ; Kim, JH; Ahn, YC; Koom, WS; Byun, HK; Kim, YH; Kim, SI; Kang, DH
    View PubMed
  • RADIOTHER ONCOL 2024 10.1016/j.radonc.2024.110436 Reduced frequency and severity of radiation esophagitis without marginal failure risk by contralateral esophagus sparing IMRT in stage III non-small cell lung cancer patients undergoing definitive concurrent chemoradiotherapy Lim, HS; Yang, K; Noh, JM; Pyo, H; Kim, JM; Kwon, D; Ju, SG; Ahn, YC
    View PubMed
  • CANCER RES TREAT 2024 10.4143/crt.2024.619 Editor's Note on Recent Journal Impact Factor of Cancer Research and Treatment Ahn, YC
    View PubMed
  • CANCER RES TREAT 2024 10.4143/crt.2023.920 The Clinical Efficacy of Colorectal Cancer Patients with Pulmonary Oligometastases by Sterotactic Body Ablative Radiotherapy: A Meta-Analysis Jeong, JU; Rim, CH; Yoo, GS; Cho, WK; Chie, EK; Ahn, YC; Lee, JH
    View PubMed
  • CURR ONCOL 2024 10.3390/curroncol31060245 Radiation Oncologists' Perspectives on Oligometastatic Prostate Cancer: A Survey from Korean Oligometastasis Working Group Yoo, GS; Park, S; Rim, CH; Cho, WK; Chang, AR; Kim, YS; Ahn, YC; Chie, EK
    View PubMed
  • CANCERS 2024 10.3390/cancers16061235 Clinical Outcomes in Adenoid Cystic Carcinoma of the Nasal Cavity and Paranasal Sinus: A Comparative Analysis of Treatment Modalities Lee, TH; Kim, K; Oh, D; Yang, K; Jeong, HS; Chung, MK; Ahn, YC
    View PubMed
  • ECLINICALMEDICINE 2024 10.1016/j.eclinm.2024.102478 Role of invasive mediastinal nodal staging in survival outcomes of patients with non-small cell lung cancer and without radiologic lymph node metastasis: a retrospective cohort study Kim, HK; Jeon, YJ; Um, SW; Shin, SH; Jeong, BH; Lee, K; Kim, H; Lee, HY; Kim, TJ; Lee, KS; Choi, YL; Han, JH; Ahn, YC; Pyo, H; Noh, JM; Choi, JY; Cho, JH; Choi, YS; Zo, JI; Shim, YM; Hwang, SS; Kim, J
    View PubMed
  • CANCER RES TREAT 2024 10.4143/crt.2023.876 Radiation Oncologists' Perspectives on Oligometastatic Disease: A Korean Survey Study Rim, CH; Cho, WK; Lee, JH; Kim, YS; Suh, YG; Kim, KH; Chang, AR; Chie, EK; Ahn, YC
    View PubMed
  • FRONT NEUROL 2024 10.3389/fneur.2023.1317858 Different decision-making in spine metastasis management among radiation oncologists and orthopedic surgeons: a Korean online survey study Byun, HK; Koom, WS; Park, SJ; Kim, SI; Kim, JH; Kim, YH; Chang, BS; Ahn, YC
    View PubMed
  • J PERS MED 2024 10.3390/jpm14010071 Prognostic Value of Radiomic Analysis Using Pre- and Post-Treatment 18F-FDG-PET/CT in Patients with Laryngeal Cancer and Hypopharyngeal Cancer Choi, JH; Choi, JY; Woo, SK; Moon, JE; Lim, CH; Park, SB; Seo, S; Ahn, YC; Ahn, MJ; Moon, SH; Park, JM
    View PubMed
  • INT J RADIAT ONCOL 2023 10.1016/j.ijrobp.2023.08.006 In Reply to Liu and Luo Kim, K; Ahn, YC
    View PubMed
  • INT J RADIAT ONCOL 2023 10.1016/j.ijrobp.2023.05.038 Can Definitive Radiation Therapy Substitute Surgical Resection in Locally Advanced T3 or T4 Sinonasal Squamous Cell Carcinoma? Kim, K; Ahn, YC; Oh, D; Noh, JM; Jeong, HS; Chung, MK; Hong, SD; Baek, CH
    View PubMed
  • RADIOTHER ONCOL 2023 10.1016/j.radonc.2023.109982 Outcomes following hypofractionated radiation therapy alone for surgically unfit early esophageal squamous cell carcinoma patients; a retrospective single center analysis Kim, K; Oh, D; Noh, JM; Min, YW; Kim, HK; Ahn, YC
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2023.479 Differential Perspectives by Specialty on Oligometastatic Colorectal Cancer: A Korean Oligometastasis Working Group's Comparative Survey Study Cho, WK; Yoo, GS; Rim, CH; Jeong, JU; Chie, EK; Ahn, YC; Cho, HM; Um, JW; Suh, YG; Chang, AR; Lee, JH
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2022.1581 Sublobar Resection versus Stereotactic Body Radiation Therapy for Clinical Stage I Non-Small Cell Lung Cancer: A Study Using Data from the Korean Nationwide Lung Cancer Registry Yun, J; Cho, JH; Hong, TH; Yang, K; Ahn, YC; Kim, HK; Korea Cent Canc Registry
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2022.1046 Outcomes of Salvage Therapy for Oropharyngeal Cancer Recurrence Following Upfront Radiation Therapy and Prognostic Factors Choi, N; Kim, HJ; Yi, H; Kim, H; Kim, TH; Jeong, HS; Son, YI; Baek, CH; Oh, D; Ahn, YC; Chung, MK
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2023.502 Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Kim, H; Park, S; Jung, HA; Lee, SH; Park, K; Ahn, YC; Oh, D; Ahn, MJ
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2023.780 Barriers in Oligometastasis Care in Korea: Radiation Oncologists' Perspectives Chie, EK; Rim, CH; Cho, WK; Ahn, YC
    View PubMed
  • JPN J CLIN ONCOL 2023 10.1093/jjco/hyad106 Recent trends in radiotherapy use for major cancers in Korea Yang, K; Lee, JE; Park, W; Ahn, YC; Huh, SJ
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2022.1305 The Incidence and Risk Factors of Chronic Pulmonary Infection after Radiotherapy in Patients with Lung Cancer Choi, Y; Noh, JM; Shin, SH; Lee, KYJ; Um, SW; Kim, H; Pyo, H; Ahn, YC; Jeong, BH
    View PubMed
  • CANCERS 2023 10.3390/cancers15143540 Detection of Cancer Recurrence Using Systemic Inflammatory Markers and Machine Learning after Concurrent Chemoradiotherapy for Head and Neck Cancers So, YK; Kim, Z; Cheong, TY; Chung, MJ; Baek, CH; Son, YI; Seok, J; Jung, YS; Ahn, MJ; Ahn, YC; Oh, D; Cho, BH; Chung, MK
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2022.1599 Metastasis-Directed Local Therapy of Hepatic Oligometastasis from Colorectal Cancer and Future Perspective in Radiation Therapy Yoo, GS; Rim, CH; Cho, WK; Jeong, JU; Chie, EK; Cho, HM; Um, JW; Ahn, YC; Lee, JH
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2022.389 Recent Trends of Medical Expenses Associated with Radiation Therapy in Korea Based on HIRA Big Data Lee, JE; Yang, K; Ahn, YC; Park, W; Huh, SJ
    View PubMed
  • CANCER MANAG RES 2023 10.2147/CMAR.S407837 Real-World Data Analysis of Survival Outcomes and Central Nervous System Relapses in Testicular Diffuse Large B Cell Lymphoma Lee, YP; Yoon, SE; Cho, J; Ko, YH; Oh, D; Ahn, YC; Kim, WS; Kim, SJ
    View PubMed
  • SCI REP-UK 2023 10.1038/s41598-023-35582-x The prognostic value of radiomic features from pre- and post-treatment F-18-FDG PET imaging in patients with nasopharyngeal carcinoma Kim, SJ; Choi, JY; Ahn, YC; Ahn, MJ; Moon, SH
    View PubMed
  • MODERN PATHOL 2023 10.1016/j.modpat.2023.100184 Whole-Section Landscape Analysis of Molecular Subtypes in Curatively Resected Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Significance Hwang, S; Hong, TH; Kim, HK; Choi, YS; Zo, JI; Shim, YM; Han, J; Ahn, YC; Pyo, H; Noh, JM; Lee, HY; Kim, HJ; Park, S; Ahn, MJ; Park, K; Lee, SH; Choi, YL; Kim, J
    View PubMed
  • RADIOTHER ONCOL 2023 10.1016/j.radonc.2023.109572 Regional lymph node recurrence after stereotactic body radiation therapy for lung cancer: Patterns of recurrence, treatment approaches, and clinical outcomes (KROG 21-09) Lee, TH; Shin, H; Ahn, YC; Kang, MK; Song, CH; Kim, WC; Moon, SH; Kim, JH; Cho, J; Park, HJ; Lee, HK; Kim, BH; Kim, HJ
    View PubMed
  • INT J RADIAT ONCOL 2023 10.1016/j.ijrobp.2022.07.018 Association of T Cell Senescence with Radiation Pneumonitis in Patients with Non-small Cell Lung Cancer Kim, KH; Pyo, H; Lee, H; Oh, D; Noh, JM; Ahn, YC; Kim, CG; Yoon, HI; Lee, J; Park, S; Jung, HA; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ku, BM; Shin, EC; Ahn, MJ
    View PubMed
  • CANCER RES TREAT 2023 10.4143/crt.2023.265 Oligometastasis: More Lessons to Be Learned Kim, KH; Ahn, YC; Korea Canc Assoc
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2022.329 Role of Local Treatment for Oligometastasis: A Comparability-Based Meta-Analysis Rim, CH; Cho, WK; Lee, JH; Kim, YS; Suh, YG; Kim, KH; Chie, EK; Ahn, YC
    View PubMed
  • CANCERS 2022 10.3390/cancers14174152 Clinical Outcomes Following Proton and Photon Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer Bae, BK; Yang, K; Noh, JM; Pyo, H; Ahn, YC
    View PubMed
  • RADIAT ONCOL 2022 10.1186/s13014-022-02124-0 Dosimetric comparison between VMAT plans using the fast-rotating O-ring linac with dual-layer stacked MLC and helical tomotherapy for nasopharyngeal carcinoma Ju, SG; Ahn, YC; Kim, YB; Kim, JM; Kwon, DY; Park, BS; Yang, K
    View PubMed
  • INT J RADIAT ONCOL 2022 10.1016/j.ijrobp.2022.02.003 Dynamics of Circulating Immune Cells During Chemoradiotherapy in Patients with Non-Small Cell Lung Cancer Support Earlier Administration of Anti-PD-1/PD-L1 Kim, KH; Pyo, H; Lee, H; Oh, D; Noh, JM; Ahn, YC; Yoon, HI; Moon, H; Lee, J; Park, S; Jung, HA; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ku, BM; Ahn, MJ; Shin, EC
    View PubMed
  • LIFE-BASEL 2022 10.3390/life12020292 Toxicity of Proton Therapy versus Photon Therapy on Salvage Re-Irradiation for Non-Small Cell Lung Cancer Yang, K; Suh, YG; Shin, H; Pyo, H; Moon, SH; Ahn, YC; Oh, D; Chung, E; Jo, K; Noh, JM
    View PubMed
  • ESMO OPEN 2022 10.1016/j.esmoop.2022.100385 Adjuvant durvalumab for esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy: a placebo-controlled, randomized, double-blind, phase II study Park, S; Sun, JM; Choi, YL; Oh, D; Kim, HK; Lee, T; Chi, SA; Lee, SH; Choi, YS; Jung, SH; Ahn, MJ; Ahn, YC; Park, K; Shim, YM
    View PubMed
  • CANCERS 2022 10.3390/cancers14030632 Clinical Value of Surveillance F-18-fluorodeoxyglucose PET/CT for Detecting Unsuspected Recurrence or Second Primary Cancer in Non-Small Cell Lung Cancer after Curative Therapy Lim, CH; Park, SB; Kim, HK; Choi, YS; Kim, J; Ahn, YC; Ahn, MJ; Choi, JY
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2020.1349 Re-irradiation with Moderate Hypo-fractionation Using Intensity Modulated Photon or Proton Radiation Therapy in Locally Recurrent Squamous Cell Carcinoma of Nasopharynx Nam, H; Ahn, YC; Yang, K; Oh, D; Noh, JM
    View PubMed
  • CANCER RES TREAT 2022 10.4143/crt.2020.1197 Oncological and Functional Outcomes of Larynx-Preserving Surgery for Hypopharyngeal Cancer: A Comparison with Definitive Radiation-Based Treatment Kim, D; Kim, N; Koh, S; Chung, MK; Son, YI; Oh, D; Jeong, HS; Ahn, YC
    View PubMed
  • FRONT PHYS-LAUSANNE 2021 10.3389/fphy.2021.680820 Tongue Displacement Device in Decreasing the Radiation Dose to Tongue and Preventing Proton Beam Overshoot in Proton Therapy for Unilateral Head and Neck Cancer Hong, CS; Oh, D; Ju, SG; Ahn, YC; Kim, YB; Park, S; Lee, W
    View PubMed
  • CANCER RES TREAT 2021 10.4143/crt.2021.707 The Rise of Particle Beam Therapy: Are We Ready for The Potential Game-Changer? Chie, EK; Ahn, YC
    View PubMed
  • J BONE ONCOL 2021 10.1016/j.jbo.2021.100368 Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases Kim1, H; Pyo, H; Park, HC; Lim, DH; Yu, JI; Park, W; Ahn, YC; Choi, DH; Oh, D; Noh, JM; Cho, WK; Yoo, GS; Jung, SH; Kim, ES; Lee, SH; Park, SJ; Lee, CS
    View PubMed
  • CANCERS 2021 10.3390/cancers13071549 Early Clinical Outcomes of Intensity Modulated Radiation Therapy/Intensity Modulated Proton Therapy Combination in Comparison with Intensity Modulated Radiation Therapy Alone in Oropharynx Cancer Patients Yoon1, HG; Ahn, YC; Oh, D; Noh, JM; Park, SG; Nam, H; Ju, SG; Kwon, D; Park, S
    View PubMed
  • CANCERS 2021 10.3390/cancers13081913 Prognostic Value of the Neutrophil-to-Lymphocyte Ratio before and after Radiotherapy for Anaplastic Thyroid Carcinoma Park1, J; Park, J; Shin, JH; Oh, YL; Jung, HA; Chung, MK; Choe, JH; Ahn, YC; Kim, SW; Chung, JH; Kim, TH; Noh, JM
    View PubMed
  • ORAL ONCOL 2021 10.1016/j.oraloncology.2021.105180 Clinical features of post-radiation nasopharyngeal necrosis and their outcomes following surgical intervention in nasopharyngeal cancer patients Yang1, K; Ahn, YC; Nam, H; Hong, SD; Oh, D; Noh, JM
    View PubMed
  • KOREAN J INTERN MED 2021 10.3904/kjim.2019.161 Induction chemotherapy followed by concurrent chemoradiotherapy versus CCRT for locally advanced hypopharynx and base of tongue cancer Lim1, SH; Sun, JM; Hong, J; Oh, D; Ahn, YC; Chung, MK; Jeong, HS; Son, YI; Ahn, MJ; Baek, CH; Park, K
    View PubMed
  • CANCER RES TREAT 2021 10.4143/crt.2020.572 Development of a Tongue Immobilization Device Using a 3D Printer for Intensity Modulated Radiation Therapy of Nasopharyngeal Cancer Patients Ju1, SG; Ahn, YC; Kim, YB; Park, SG; Choi, YM; Na, CH; Hong, CS; Oh, D; Kwon, DY; Kim, CC; Kim, DH
    View PubMed
  • J THORAC DIS 2020 10.21037/jtd-20-667 Treatment modality and outcomes among early-stage non-small cell lung cancer patients with COPD a cohort study Kang1, N; Shin, SH; Noh, JM; Kang, D; Kim, H; Kwon, OJ; Pyo, H; Ahn, YC; Kim, HK; Choi, YS; Kim, J; Zo, JI; Shim, YM; Cho, J; Park, HY
    View PubMed
  • LUNG CANCER 2020 10.1016/j.lungcan.2020.05.035 Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer Jung1, HA; Noh, JM; Sun, JM; Lee, SH; Ahn, JS; Ahn, MJ; Pyo, H; Ahn, YC; Park, K
    View PubMed
  • Journal of thoracic disease 2020 10.21037/jtd.2020.03.23 Adjuvant therapy in stage IIIA-N2 non-small cell lung cancer after neoadjuvant concurrent chemoradiotherapy followed by surgery Shin1, S; Kim, HK; Cho, JH; Choi, YS; Kim, K; Kim, J; Zo, JI; Sun, JM; Ahn, MJ; Park, K; Pyo, H; Ahn, YC; Shim, YM
    View PubMed
  • CANCERS 2020 10.3390/cancers12040925 Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer Yoon1, HG; Oh, D; Ahn, YC; Noh, JM; Pyo, H; Cho, WK; Song, YM; Park, M; Hwang, NY; Sun, JM; Kim, HK; Zo, JI; Shim, YM
    View PubMed
  • J THORAC ONCOL 2020 10.1016/j.jtho.2019.10.022 Asian Thoracic Oncology Research Group Expert Consensus Statement on Optimal Management of Stage III NSCLC Tan1, WL; Chua, KLM; Lin, CC; Lee, VHF; Tho, LM; Chan, AW; Ho, GF; Reungwetwattana, T; Yang, JC; Kim, DW; Soo, RA; Ahn, YC; Onishi, H; Ahn, MJ; Mok, TSK; Tan, DSW; Yang, F
    View PubMed
  • ANN ONCOL 2020 10.1016/j.annonc.2019.10.026 Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS Park1, K; Vansteenkiste, J; Lee, KH; Pentheroudakis, G; Zhou, C; Prabhash, K; Seto, T; Voon, PJ; Tan, DSW; Yang, JCH; Wang, J; Babu, KG; Nakayama, Y; Alip, A; Chua, KLM; Cheng, JCH; Senan, S; Ahn, YC; Kim, TY; Ahn, HK; Peters, S; Yoshino, T; Douillard, JY
    View PubMed
  • HEAD NECK-J SCI SPEC 2020 10.1002/hed.26067 Prevalence of NUT carcinoma in head and neck: Analysis of 362 cases with literature review Lee1, T; Cho, J; Baek, CH; Son, YI; Jeong, HS; Chung, MK; Hong, SD; Ahn, YC; Oh, DR; Noh, JM; Park, K; Ahn, MJ; Kim, HJ; Kim, YK; Ko, YH
    View PubMed
  • RESP RES 2020 10.1186/s12931-019-1254-0 Impact of diffusing lung capacity before and after neoadjuvant concurrent chemoradiation on postoperative pulmonary complications among patients with stage IIIA/N2 non-small-cell lung cancer Shin1, S; Choi, YS; Jung, JJ; Im, Y; Shin, SH; Kang, D; Cho, JH; Kim, HK; Kim, J; Zo, JI; Shim, YM; Park, K; Ahn, MJ; Ahn, YC; Lee, G; Cho, J; Lee, HY; Park, HY
    View PubMed
  • INT J RADIAT ONCOL 2019 10.1016/j.ijrobp.2019.06.2540 International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma Lee1, AW; Ng, WT; Pan, JJ; Chiang, CL; Poh, SS; Choi, HC; Ahn, YC; AlHussain, H; Corry, J; Grau, C; Gregoire, V; Harrington, KJ; Hu, CS; Kwong, DL; Langendijk, JA; Le, QT; Lee, NY; Lin, JC; Lu, TX; Mendenhall, WM; O'Sullivan, B; Ozyar, E; Peters, LJ; Rosenthal, DI; Sanguineti, G; Soong, YL; Tao, YA; Yom, SS; Wee, JT
    View PubMed
  • Journal of thoracic disease 2019 10.21037/jtd.2019.10.18 Improved clinical outcomes following additional aggressive local consolidative therapy to systemic therapy for oligometastasis from lung cancer: where do we stand between "reality" and "illusion"? Nam1, H; Noh, JM; Park, SG; Ahn, YC
    View PubMed
  • Int J Chron Obstruct Pulmon Dis 2019 10.2147/COPD.S210759 Impact Of Underlying Pulmonary Diseases On Treatment Outcomes In Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiotherapy Kim1, H; Yoo, H; Pyo, H; Ahn, YC; Noh, JM; Ju, SG; Lee, W; Park, B; Kim, JM; Kang, N; Shin, SH; Chung, MP; Shin, S; Kim, HS; Park, M; Park, HY
    View PubMed
  • J RADIAT RES 2019 10.1093/jrr/rrz040 Role of prophylactic cranial irradiation for elderly patients with limited-disease small-cell lung cancer: inverse probability of treatment weighting using propensity score Kim1, TG; Pyo, H; Ahn, YC; Noh, JM; Oh, D
    View PubMed
  • CANCER SCI 2019 10.1111/cas.14115 Early clinical outcomes of helical tomotherapy/intensity-modulated proton therapy combination in nasopharynx cancer Park1, SG; Ahn, YC; Oh, D; Noh, JM; Ju, SG; Kwon, D; Jo, K; Chung, K; Chung, E; Lee, W; Park, S
    View PubMed
  • EUR J NUCL MED MOL I 2019 10.1007/s00259-019-04387-4 Diagnostic value of surveillance F-18-fluorodeoxyglucose PET/CT for detecting recurrent esophageal carcinoma after curative treatment Kim1, SJ; Hyun, SH; Moon, SH; Lee, KS; Sun, JM; Oh, D; Ahn, YC; Zo, JI; Shim, YM; Choi, JY
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.415 Dummy Run of Quality Assurance Program before Prospective Study of Hippocampus-Sparing Whole-Brain Radiotherapy and Simultaneous Integrated Boost for Multiple Brain Metastases from Non-small Cell Lung Cancer: Korean Radiation Oncology Group (KROG) 17-06 Study Chung1, E; Noh, JM; Lee, KC; Kim, JH; Chung, WK; Suh, YG; Lee, JA; Seol, KH; Wu, HG; Kim, YS; Noh, OK; Park, JW; Lee, DS; Lee, J; Kim, YS; Park, WY; Kang, MK; Jo, S; Ahn, YC
    View PubMed
  • RADIAT ONCOL 2019 10.1186/s13014-019-1289-x Development of a semi-customized tongue displacement device using a 3D printer for head and neck IMRT Hong1, CS; Oh, D; Ju, SG; Ahn, YC; Na, CH; Kwon, DY; Kim, CC
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.240 Feasibility of Selective Neck Irradiation with Lower Elective Radiation Dose in Treating Nasopharynx Cancer Patients Cho1, WK; Oh, D; Lee, E; Kim, TG; Lee, H; Nam, H; Noh, JM; Ahn, YC
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.190 Radiation Therapy Outcome and Clinical Features of Duodenal-Type Follicular Lymphoma Lee1, H; Oh, D; Yang, K; Ko, YH; Ahn, YC; Kim, WS; Kim, SJ
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.125 EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy Park1, SE; Noh, JM; Kim, YJ; Lee, HS; Cho, JH; Lim, SW; Ahn, YC; Pyo, H; Choi, YL; Han, J; Sun, JM; Lee, SH; Ahn, JS; Park, K; Ahn, MJ
    View PubMed
  • RADIOTHER ONCOL 2019 10.1016/j.radonc.2019.01.005 Dosimetric predictors for postoperative pulmonary complications in esophageal cancer following neoadjuvant chemoradiotherapy and surgery Cho1, WK; Oh, D; Kim, HK; Ahn, YC; Noh, JM; Shim, YM; Zo, JI; Choi, YS; Sun, JM; Lee, SH; Ahn, MJ; Park, K; Nam, H
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2018.366 Salvage Concurrent Chemo-radiation Therapy for Loco-regional Recurrence Following Curative Surgery of Non-small Cell Lung Cancer Lee1, KH; Ahn, YC; Pyo, H; Noh, JM; Park, SG; Kim, TG; Lee, E; Nam, H; Lee, H; Sun, JM; Ahn, JS; Ahn, MJ; Park, K
    View PubMed
  • J RADIAT RES 2019 10.1093/jrr/rry102 Concurrent chemo-radiotherapy for unresectable non-small cell lung cancer invading adjacent great vessels on radiologic findings: is it safe? Yoo1, GS; Oh, D; Pyo, H; Ahn, YC; Noh, JM; Park, HC; Lim, DH
    View PubMed
  • CANCER RES TREAT 2019 10.4143/crt.2017.273 The Effect of Hospital Case Volume on Clinical Outcomes in Patients with Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Analysis (KROG-1106) Ha1, B; Cho, KH; Moon, SH; Lee, CG; Keum, KC; Kim, YS; Wu, HG; Kim, JH; Ahn, YC; Oh, D; Noh, JM; Lee, JH; Kim, SH; Kim, WT; Oh, YT; Kang, MK; Kim, JH; Kim, JY; Cho, MJ; Kay, CS; Choi, JH
    View PubMed
  • RADIAT ONCOL 2018 10.1186/s13014-018-1196-6 Clinical outcomes of radiation therapy for clinical T4b oesophageal cancer with airway invasion Kim1, H; Oh, D; Ahn, YC; Park, K; Ahn, MJ; Lee, SH; Sun, JM; Shim, YM; Zo, JI; Choi, YS; Kim, HK; Cho, JH
    View PubMed
  • INT J RADIAT ONCOL 2018 10.1016/j.ijrobp.2018.07.2022 Patterns of Failure Following Postoperative Radiation Therapy Based on "Tumor Bed With Margin" for Stage II to IV Type C Thymic Epithelial Tumor Lee1, KH; Noh, JM; Ahn, YC; Oh, D; Kim, J; Shim, YM; Han, JH
    View PubMed
  • CANCER RES TREAT 2018 10.4143/crt.2017.182 Low-Dose Radiation Therapy for Primary Conjunctival Marginal Zone B-Cell Lee1, GI; Oh, D; Kim, WS; Kim, SJ; Ko, YH; Woo, KI; Kim, YD; Ahn, YC
    View PubMed
  • LUNG CANCER 2018 10.1016/j.lungcan.2017.11.020 Recurrence dynamics after trimodality therapy (Neoadjuvant concurrent chemoradiotherapy and surgery) in patients with stage IIIA (N2) lung cancer Lee1, J; Kim, HK; Park, BJ; Cho, JH; Choi, YS; Zo, JI; Shim, YM; Pyo, H; Ahn, YC; Ahn, JS; Ahn, MJ; Park, K; Kim, J
    View PubMed
  • RADIOTHER ONCOL 2018 10.1016/j.radonc.2017.10.032 International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma Lee1, AW; Ng, WT; Pan, JJ; Poh, SS; Ahn, YC; AlHussain, H; Corry, J; Grau, C; Gregoire, V; Harrington, KJ; Hu, CS; Kwong, DL; Langendijk, JA; Le, QT; Lee, NY; Lin, JC; Lu, TX; Mendenhall, WM; O'Sullivan, B; Ozyar, E; Peters, LJ; Rosenthal, DI; Soong, YL; Tao, YG; Yom, SS; Wee, JT
    View PubMed
  • HEAD NECK-J SCI SPEC 2018 10.1002/hed.24980 Efficacy of postoperative neck irradiation for regional control in patients with pN0 oral tongue cancer: Propensity analysis So1, YK; Oh, D; Choi, N; Baek, CH; Ahn, YC; Chung, MK
    View PubMed
  • J THORAC ONCOL 2017 10.1016/j.jtho.2017.09.1954 Randomized Phase II Trial Comparing Chemoradiotherapy with Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer Sun1, JM; Noh, JM; Oh, D; Kim, HK; Lee, SH; Choi, YS; Pyo, H; Ahn, JS; Jung, SH; Ahn, YC; Kim, J; Ahn, MJ; Zo, JI; Shim, YM; Park, K
    View PubMed
  • RADIAT ONCOL 2017 10.1186/s13014-017-0905-x Normal lung sparing Tomotherapy technique in stage III lung cancer Hong1, CS; Ju, SG; Ahn, YC; Yoo, GS; Noh, JM; Oh, D; Chung, K; Pyo, H; Jo, K
    View PubMed
  • JPN J CLIN ONCOL 2017 10.1093/jjco/hyx120 Whole brain radiation dose reduction for primary central nervous system lymphoma patients who achieved partial response after high-dose methotrexate based chemotherapy Park1, JS; Lim, DH; Ahn, YC; Park, W; Kim, SJ; Kim, WS; Kim, K
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.442 Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute Experience Park1, H; Oh, D; Ahn, YC; Pyo, H; Noh, JM; Sun, JM; Ahn, JS; Ahn, MJ; Park, K; Kim, HK; Choi, YS; Kim, J; Zo, JI; Shim, YM
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.425 Comparison of the Clinical Outcomes of Patients with Squamous Cell Carcinoma of the Tonsil Receiving Postoperative Ipsilateral Versus Bilateral Neck Radiotherapy: A Propensity Score Matching Analysis (KROG 11-07) Kim1, Y; Cho, KH; Moon, SH; Lee, CG; Keum, KC; Lee, SW; Ahn, YC; Oh, D; Kim, YS; Won, YK; Wu, HG; Hah, JH; Oh, YT
    View PubMed
  • BMC CANCER 2017 10.1186/s12885-017-3571-3 Chemoradiotherapy versus surgery followed by postoperative radiotherapy in tonsil cancer: Korean Radiation Oncology Group (KROG) study Song1, S; Wu, HG; Lee, CG; Keum, KC; Kim, MS; Ahn, YC; Oh, D; Park, HJ; Lee, SW; Park, G; Moon, SH; Cho, KH; Kim, YS; Won, Y; Oh, YT; Kim, WT; Jeong, JU
    View PubMed
  • CANCER RES TREAT 2017 10.4143/crt.2016.219 Survey of the Patterns of Using Stereotactic Ablative Radiotherapy for Early-Stage Non-small Cell Lung Cancer in Korea Song1, S; Chang, JH; Kim, HJ; Kim, YS; Kim, JH; Ahn, YC; Kim, JS; Song, SY; Moon, SH; Cho, MJ; Youn, SM
    View PubMed
  • Pathol Res Pract. 2017 Feb;213(2):106-112. doi: 10.1016/j.prp.2016.11.012. Epub 2016 Nov 15. Histologic characteristics of thymic adenocarcinomas: Clinicopathologic study of a nine-case series and a review of the literature Kwon AY11, Han J2, Chu J1, Choi YS3, Jeong BH4, Ahn MJ5, Ahn YC6.
    View PubMed
  • RADIOTHERAPY AND ONCOLOGY, FEB 2017, 122(2):217-223, DOI: 10.1016/j.radonc.2016.09.015 A phase II trial of concurrent chemoradiotherapy with weekly docetaxel plus cisplatin treatment for unresectable locally advanced head and neck cancer Lee JY1, Sun JM, Oh D, Lim SH, Chi S, Lee SH, Jung SH, Ahn MJ, Ahn YC, Park K
    View PubMed
  • J Radiat Res. 2017 Jan;58(1):155-163. doi: 10.1093/jrr/rrw089. Epub 2016 Sep 26. Spine Metastasis Practice Patterns among Korean, Chinese, and Japanese Radiation Oncologists: A Multinational Online Survey Study Yu JI11, Park HC2,3, Ahn YC1,3, Gao XS4, Wang JJ5, Zeng ZC6, Ito Y7, Ohno T8, Nishimura Y9.
    View PubMed
  • Oncotarget. 2017 Jan 10;8(2):3542-3552. doi: 10.18632/oncotarget.12200. Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery Cho WK11, Oh D1, Ahn YC1, Shim YM2, Zo JI2, Sun JM3, Ahn MJ3, Park K3.
    View PubMed
  • J Thorac Oncol. 2016 Dec;11(12):2202-2207. doi: 10.1016/j.jtho.2016.07.005. Epub 2016 Jul 14. Do New pN Subclassifications Proposed by IASLC's Lung Cancer Staging Project Agree with ypN Categories after Trimodality Therapy for Initial N2 Disease? Kim H11, Ahn YC2, Pyo H1, Oh D1, Noh JM1, Sun JM3, Ahn JS3, Ahn MJ3, Park K3, Choi YS4, Kim J4, Zo JI4, Shim YM4, Lee M5, Han J5.
    View PubMed
  • Ann Surg Oncol. 2016 Dec;23(13):4368-4375. Epub 2016 Jun 24. Low-Grade Salivary Gland Cancers: Treatment Outcomes, Extent of Surgery and Indications for Postoperative Adjuvant Radiation Therapy Cho JK11, Lim BW1, Kim EH2, Ko YH3, Oh D4, Noh JM4, Ahn YC4, Baek KH5, Jeong HS6.
    View PubMed
  • BRITISH JOURNAL OF RADIOLOGY, 2016, 89(1067), DOI: 10.1259/bjr.20160109 Value of F-18-FDG heterogeneity for discerning metastatic from benign lymph nodes in nasopharyngeal carcinoma patients with suspected recurrence Moon SH1, Cho YS, Son YI, Ahn YC, Ahn MJ, Choi JY, Kim BT, Lee KH
    View PubMed
  • Cancer Res Treat. 2016 Oct;48(4):1187-1195. Epub 2016 Mar 9. Radiation Therapy Alone in cT1-3N0 Non-small Cell Lung Cancer Patients Who Are Unfit for Surgical Resection or Stereotactic Radiation Therapy: Comparison of Risk-Adaptive Dose Schedules Cho WK11, Noh JM1, Ahn YC1, Oh D1, Pyo H1.
    View PubMed
  • Otolaryngol Head Neck Surg. 2016 Sep;155(3):423-30. doi: 10.1177/0194599816642418. Epub 2016 Apr 5. Randomized Trial of Vitamin C/E Complex for Prevention of Radiation-Induced Xerostomia in Patients with Head and Neck Cancer Chung MK11, Kim do H2, Ahn YC3, Choi JY4, Kim EH1, Son YI5.
    View PubMed
  • Oncotarget. 2016 Sep 13;7(37):60639-60646. doi: 10.18632/oncotarget.10259. Clinical significance of post-surgical residual tumor burden and radiation therapy in treating patients with lacrimal adenoid cystic carcinoma Noh JM11, Lee E1, Ahn YC1, Oh D1, Kim YD2, Woo KI2, Ko YH3, Kim S3.
    View PubMed
  • Medicine (Baltimore). 2016 Aug;95(33):e4591. doi: 10.1097/MD.0000000000004591. High-dose radiation therapy alone by moderate hypofractionation for patients with thoracic esophageal squamous cell carcinoma Oh D11, Noh JM, Nam H, Lee H, Kim TG, Ahn YC.
    View PubMed
  • Cancer Res Treat. 2016 Jul;48(3):917-27. doi: 10.4143/crt.2015.265. Epub 2015 Dec 28. The Role of Neoadjuvant Chemotherapy in the Treatment of Nasopharyngeal Carcinoma: A Multi-institutional Retrospective Study (KROG 11-06) Using Propensity Score Matching Analysis Song JH11, Wu HG2, Keam BS3, Hah JH4, Ahn YC5, Oh D5, Noh JM5, Park HJ5, Lee CG6, Keum KC6, Cha J6, Cho KH7, Moon SH7, Kim JY8, Chung WK9, Oh YT10, Kim WT11, Cho MJ12, Kay CS13, Kim YS14.
    View PubMed
  • Cancer Res Treat. 2016 Jul;48(3):1102-9. doi: 10.4143/crt.2015.207. Epub 2015 Dec 2. Variation in Practice Patterns of Korean Radiation Oncologists for Spine Metastasis between 2009 and 2014 Yu JI11, Park HC1,2, Ahn YC1,2, Chung Y1, Koom WS3, Song SY4.
    View PubMed
  • Strahlenther Onkol. 2016 Jun;192(6):377-85. doi: 10.1007/s00066-016-0959-y. Epub 2016 Mar 14. IMRT vs. 2D-radiotherapy or 3D-conformal radiotherapy of nasopharyngeal carcinoma Survival outcome in a Korean multi-institutional retrospective study (KROG 11-06) Moon SH11, Cho KH2, Lee CG3, Keum KC3, Kim YS4, Wu HG5, Kim JH5, Ahn YC6, Oh D6, Lee JH7.
    View PubMed
  • Ann Surg Oncol. 2016 Jun;23(6):2054-61. doi: 10.1245/s10434-016-5088-4. Epub 2016 Jan 19. Comparison of Oncological and Functional Outcomes between Initial Surgical versus Non-Surgical Treatments for Hypopharyngeal Cancer Jang JY11, Kim EH2, Cho J2, Jung JH3, Oh D4, Ahn YC4, Son YI2, Jeong HS5.
    View PubMed
  • Lung Cancer. 2016 Jun;96:56-62. doi: 10.1016/j.lungcan.2016.03.016. Epub 2016 Mar 29. Outcomes of neoadjuvant concurrent chemoradiotherapy followed by surgery for non-small-cell lung cancer with N2 disease Kim HK11, Cho JH1, Choi YS1, Zo JI1, Shim YM1, Park K2, Ahn MJ2, Ahn YC3, Kim K4, Kim J5.
    View PubMed
  • Cancer Res Treat. 2016 Apr;48(2):527-36. doi: 10.4143/crt.2015.249. Epub 2015 Sep 15. Association between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma Kim HS11, Lee JY1, Lim SH1, Park K1, Sun JM1, Ko YH2, Baek CH3, Son YI3, Jeong HS3, Ahn YC4, Lee MY5, Hong M6, Ahn MJ1.
    View PubMed
  • Cancer Res Treat. 2016 Apr;48(2):537-45. doi: 10.4143/crt.2015.081. Epub 2015 Jul 14. Tumor Volume Reduction Rate during Adaptive Radiation Therapy as a Prognosticator for Nasopharyngeal Cancer Lee H11, Ahn YC2, Oh D2, Nam H1, Noh JM2, Park SY2,3.
    View PubMed
  • Head Neck. 2016 Apr;38 Suppl 1:E293-9. doi: 10.1002/hed.23988. Epub 2015 Jun 26. Fate of patients with nasopharyngeal cancer who developed distant metastasis as first failure after definitive radiation therapy Chang JH11,2, Ahn YC1, Park H1, Oh D1, Noh JM1, Sun JM3, Ahn MJ3, Park K3.
    View PubMed
  • Ann Hematol. 2016 Mar;95(4):581-91. doi: 10.1007/s00277-015-2581-y. Epub 2016 Jan 4. Extra-nodal natural killer/T cell lymphoma in elderly patients: the impact of aging on clinical outcomes and treatment tolerability Kim SM11, Park S1, Oh DR2, Ahn YC2, Ko YH3, Kim SJ1, Kim WS4.
    View PubMed
  • Radiother Oncol. 2016 Feb;118(2):244-50. doi: 10.1016/j.radonc.2015.11.030. Epub 2015 Dec 17. Comparison of weekly versus triweekly cisplatin delivered concurrently with radiation therapy in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II trial (KCSG-HN10-02) Lee JY11, Sun JM1, Oh DR2, Lim SH1, Goo J3, Lee SH1, Kim SB4, Park KU5, Kim HK6, Hong DS7, Kim JS8, Kim SG9, Yi SY10, Yun HJ11, Hyun MS12, Kim HJ13, Jung SH3, Park K1, Ahn YC14, Ahn MJ15.
    View PubMed
  • Cancer Res Treat. 2016 Jan;48(1):106-14. doi: 10.4143/crt.2014.131. Epub 2015 Feb 12. Effect of Radiation Therapy Techniques on Outcome in N3-positive IIIB Non-small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy Noh JM11, Kim JM1, Ahn YC1, Pyo H1, Kim B1, Oh D1, Ju SG1, Kim JS1, Shin JS1, Hong CS1, Park H1, Lee E1.
    View PubMed
  • Eur J Cancer. 2016 Jan;52:1-9. doi: 10.1016/j.ejca.2015.09.019. Epub 2015 Nov 26. Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer Lim SH11, Hong M2, Ahn S3, Choi YL3, Kim KM3, Oh D4, Ahn YC4, Jung SH5, Ahn MJ1, Park K1, Zo JI6, Shim YM6, Sun JM7.
    View PubMed
  • Cancer Res Treat. 2016 Jan;48(1):63-70. doi: 10.4143/crt.2014.265. Epub 2015 Mar 6. Carotid-Sparing TomoHelical 3-Dimensional Conformal Radiotherapy for Early Glottic Cancer Hong CS11, Oh D1, Ju SG1, Ahn YC1, Noh JM1, Chung K1, Kim JS1, Suh TS2.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):677-83. doi: 10.1016/j.ijrobp.2015.07.2267. Epub 2015 Jul 22. Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type Oh D11, Ahn YC2, Kim SJ3, Kim WS3, Ko YH4.
    View PubMed
  • Int Forum Allergy Rhinol. 2015 Oct;5(10):960-6. doi: 10.1002/alr.21564. Epub 2015 Jun 3. Nasal endoscopic evaluation and its impact on survival in patients with stage I/II extranodal natural killer/T-cell lymphoma, nasal type Cho HJ11, Jang MS2, Hong SD2, Kim SJ3, Ahn YC4, Oh D4, Ko YH5, Kim HY2, Dhong HJ2, Chung SK2, Kim WS3.
    View PubMed
  • Cancer Res Treat. 2015 Oct;47(4):871-8. doi: 10.4143/crt.2014.141. Epub 2015 Feb 13. Role of Chemotherapy in Stacie II Nasopharyngeal Carcinoma Treated with Curative Radiotherapy Kang MK11, Oh D2, Cho KH3, Moon SH3, Wu HG4, Heo DS5, Ahn YC2, Park K6, Park HJ2, Park JS2, Keum KC7, Cha J7, Kim JW7, Kim YS8, Kang JH9, Oh YT10, Kim JY11, Kim SH12, Kim JH13, Lee CG7.
    View PubMed
  • Radiother Oncol. 2015 Oct;117(1):171-7. doi: 10.1016/j.radonc.2015.08.009. Epub 2015 Aug 20. Effects of adjuvant radiotherapy on completely resected gastric cancer: A radiation oncologist's view of the ARTIST randomized phase III trial Yu JI11, Lim do H2, Ahn YC1, Lee J3, Kang WK3, Park SH3, Park JO3, Park YS3, Lim HY3, Kim ST3, Kim S4, Sohn TS4, Choi MG4, Bae JM4, Nam H5.
    View PubMed
  • Cancer Res Treat. 2015 Oct;47(4):727-37. doi: 10.4143/crt.2014.018. Epub 2014 Dec 2. Dosimetric and Clinical Influence of 3D Versus 2D Planning in Postoperative Radiation Therapy for Gastric Cancer Lee JA11, Ahn YC2, Lim do H2, Park HC2, Asranbaeva MS3.
    View PubMed
  • Cancer Res Treat. 2015 Oct;47(4):645-52. doi: 10.4143/crt.2014.144. Epub 2015 Feb 12. Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung Cancer Noh JM11, Ahn YC1, Lee H2, Pyo H1, Kim B1, Oh D1, Park H1, Lee E1, Park K3, Ahn JS3, Ahn MJ3, Sun JM3.
    View PubMed
  • AJR Am J Roentgenol.?2015 Sep;205(3):623-8. doi: 10.2214/AJR.14.13847. Volume-Based Assessment With F-18-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer Hyun SH11,?Ahn HK2,?Ahn MJ3,?Ahn YC4,?Kim J5,?Shim YM5,?Choi JY1.
    View PubMed
  • J Clin Oncol. 2015 Aug 20;33(24):2660-6. doi: 10.1200/JCO.2014.60.0130. Epub 2015 Jul 6. Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04 Ahn JS11, Ahn YC1, Kim JH1, Lee CG1, Cho EK1, Lee KC1, Chen M1, Kim DW1, Kim HK1, Min YJ1, Kang JH1, Choi JH1, Kim SW1, Zhu G1, Wu YL1, Kim SR1, Lee KH1, Song HS1, Choi YL1, Sun JM1, Jung SH1, Ahn MJ1, Park K2.
    View PubMed
  • Cancer Res Treat.?2015 Jul;47(3):436-40. doi: 10.4143/crt.2013.184. Epub 2014 Nov 17. Potential Role of Adjuvant Radiation Therapy in Cervical Thymic Neoplasm Involving Thyroid Gland or Neck Noh JM11,?Ha SY2,?Ahn YC1,?Oh D1,?Seol SW1,?Oh YL2,?Han J2.
    View PubMed
  • Eur J Cancer. 2015 Jul;51(10):1303-11. doi: 10.1016/j.ejca.2015.04.003. Epub 2015 Apr 28. Development and external validation of nomograms predictive of response to radiation therapy and overall survival in nasopharyngeal cancer patients Cho JK11, Lee GJ2, Yi KI3, Cho KS3, Choi N2, Kim JS2, Kim H4, Oh D4, Choi SK5, Jung SH5, Jeong HS2, Ahn YC6.
    View PubMed
  • Clin Exp Otorhinolaryngol. 2015 Jun;8(2):142-8. doi: 10.3342/ceo.2015.8.2.142. Epub 2015 May 13. Prognostic Value of Volume-Based Positron Emission Tomography/Computed Tomography in Patients With Nasopharyngeal Carcinoma Treated With Concurrent Chemoradiotherapy Moon SH11, Choi JY1, Lee HJ1, Son YI2, Baek CH2, Ahn YC3, Ahn MJ4, Park K4, Kim BT1.
    View PubMed
  • J Thorac Oncol.?2015 Feb;10(2):331-7. doi: 10.1097/JTO.0000000000000388. Endobronchial Ultrasound versus Mediastinoscopy for Mediastinal Nodal Staging of Non-Small-Cell Lung Cancer Um SW11,?Kim HK,?Jung SH,?Han J,?Lee KJ,?Park HY,?Choi YS,?Shim YM,?Ahn MJ,?Park K,?Ahn YC,?Choi JY,?Lee KS,?Suh GY,?Chung MP,?Kwon OJ,?Kim J,?Kim H
    View PubMed
  • Cancer Chemother Pharmacol. 2015 Jan;75(1):77-85. doi: 10.1007/s00280-014-2619-1. Epub 2014 Nov 6. Predictive factors for survival in stage IIIA N2 NSCLC patients treated with neoadjuvant CCRT followed by surgery Lim HJ11, Lee HY, Lee KS, Han J, Kwon OJ, Park K, Ahn YC, Kim BT, Shim YM.
    View PubMed
  • Ann Hematol. 2014 Nov;93(11):1895-901. doi: 10.1007/s00277-014-2137-6. Epub 2014 Jun 20. Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study Kim SJ11, Yang DH, Kim JS, Kwak JY, Eom HS, Hong DS, Won JH, Lee JH, Yoon DH, Cho J, Nam TK, Lee SW, Ahn YC, Suh C, Kim WS.
    View PubMed
  • Clin Lung Cancer. 2014 Sep;15(5):346-55. doi: 10.1016/j.cllc.2014.04.003. Epub 2014 May 15. An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non-Small-Cell Lung Cancer Ashworth AB11, Senan S2, Palma DA1, Riquet M3, Ahn YC4, Ricardi U5, Congedo MT6, Gomez DR7, Wright GM8, Melloni G9, Milano MT10, Sole CV11, De Pas TM12, Carter DL13, Warner AJ1, Rodrigues GB14.
    View PubMed
  • Ann Surg Oncol. 2014 Jun;21(6):2083-90. doi: 10.1245/s10434-014-3540-x. Epub 2014 Feb 13. Pretreatment Clinical Mediastinal Nodal Bulk and Extent do not Influence Survival in N2-Positive Stage IIIA Non-small Cell Lung Cancer Patients Treated with Trimodality Therapy Lee H11, Ahn YC, Pyo H, Kim B, Oh D, Nam H, Lee E, Sun JM, Ahn JS, Ahn MJ, Park K, Choi YS, Kim J, Zo JI, Shim YM.
    View PubMed
  • Head Neck. 2014 Apr;36(4):499-504. doi: 10.1002/hed.23328. Epub 2013 Jun 18. Tumor volume reduction rate measured during adaptive definitive radiation therapy as a potential prognosticator of locoregional control in patients with oropharyngeal cancer Lee H11, Ahn YC, Oh D, Nam H, Kim YI, Park SY.
    View PubMed
  • Cancer Res Treat. 2014 Apr;46(2):148-57. doi: 10.4143/crt.2014.46.2.148. Epub 2014 Apr 22. Impact on Loco-regional Control of Radiochemotherapeutic Sequence and Time to Initiation of Adjuvant Treatment in Stage II/III Rectal Cancer Patients Treated with Postoperative Concurrent Radiochemotherapy Kim H11, Chie EK2, Ahn YC3, Kim K2, Park W3, Yoon WS4, Huh SJ3, Ha SW2.
    View PubMed
  • CANCER IMAGING, APR 22 2014, 14, 10.1186/1470-7330-14-2 Prognostic value of volumetric metabolic parameters measured by [F-18]Fluorodeoxyglucose-positron emission tomography/computed tomography in patients with small cell lung cancer Park1, SB, Choi, JY, Moon, SH, Yoo, J, Kim, H, Ahn, YC, Ahn, MJ, Park, K, Kim, BT
    View PubMed
  • Med Phys.?2014 Feb;41(2):021712. doi: 10.1118/1.4860155. Dosimetric effects of multileaf collimator leaf width on intensity-modulated radiotherapy for head and neck cancer Hong CS11,?Ju SG1,?Kim M1,?Kim JI2,?Kim JM1,?Suh TS3,?Han Y1,?Ahn YC1,?Choi DH1,?Nam H2,?Park HC1.
    View PubMed
  • PLoS One. 2014 Feb 26;9(2):e88598. doi: 10.1371/journal.pone.0088598. eCollection 2014. Quantitative CT Variables Enabling Response Prediction in Neoadjuvant Therapy with EGFR-TKIs: Are They Different from Those in Neoadjuvant Concurrent Chemoradiotherapy Chong Y11, Kim JH1, Lee HY1, Ahn YC2, Lee KS1, Ahn MJ3, Kim J4, Shim YM4, Han J5, Choi YL5.
    View PubMed
  • Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):50-8. doi: 10.1007/s00259-013-2530-8. Epub 2013 Aug 16. Volume-based assessment by F-18-FDG PET/CT predicts survival in patients with stage III non-small-cell lung cancer Hyun SH11, Ahn HK, Kim H, Ahn MJ, Park K, Ahn YC, Kim J, Shim YM, Choi JY.
    View PubMed
  • J Cancer Res Clin Oncol. 2013 Dec;139(12):2089-96. doi: 10.1007/s00432-013-1531-0. Epub 2013 Oct 10. A survey of patterns of practice on palliative radiation therapy for bone metastasis in Korea Chung Y11, Koom WS, Ahn YC, Park HC, Kim HJ, Yoon SM, Shin S, Lee YJ.
    View PubMed
  • Ann Oncol. 2013 Aug;24(8):2088-92. doi: 10.1093/annonc/mdt140. Epub 2013 Apr 16. Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer(dagger) Sun JM11, Ahn YC, Choi EK, Ahn MJ, Ahn JS, Lee SH, Lee DH, Pyo H, Song SY, Jung SH, Jo JS, Jo J, Sohn HJ, Suh C, Lee JS, Kim SW, Park K.
    View PubMed
  • J Thorac Oncol. 2013 May;8(5):624-9. doi: 10.1097/JTO.0b013e31828cb6db. Hypofractionated Three-Dimensional Conformal Radiation Therapy Alone for Centrally Located cT1-3N0 Non-Small-Cell Lung Cancer Oh D11, Ahn YC, Kim B, Pyo H.
    View PubMed
  • Yonsei Med J. 2012 Nov 1;53(6):1120-7. doi: 10.3349/ymj.2012.53.6.1120. High Dose Involved Field Radiation Therapy as Salvage for Loco-Regional Recurrence of Non-Small Cell Lung Cancer Bae SH11, Ahn YC, Nam H, Park HC, Pyo HR, Shim YM, Kim J, Kim K, Ahn JS, Ahn MJ, Park K.
    View PubMed
  • Cancer Res Treat. 2012 Sep;44(3):166-72. doi: 10.4143/crt.2012.44.3.166. Epub 2012 Sep 30. Is There a Role of Postoperative Radiation Therapy in Completely Resected Stage I/II Thymic Epithelial Tumor Oh D11, Ahn YC, Kim K, Kim J, Shim YM, Han J.
    View PubMed
  • Clin Exp Otorhinolaryngol. 2012 Jun;5(2):94-100. doi: 10.3342/ceo.2012.5.2.94. Epub 2012 Jun 12. Definitive Radiation Therapy for Early Glottic Cancer: Experience of Two Fractionation Schedules Kim TG11, Ahn YC, Nam HR, Chung MK, Jeong HS, Son YI, Baek CH.
    View PubMed
  • Med Phys. 2012 May;39(5):2396-404. doi: 10.1118/1.3700734. Development of a video-guided real-time patient motion monitoring system Ju SG11, Huh W, Hong CS, Kim JS, Shin JS, Shin E, Han Y, Ahn YC, Park HC, Choi DH.
    View PubMed
  • Acta Oncol. 2012 May;51(5):596-602. doi: 10.3109/0284186X.2012.681698. Epub 2012 May 1. Potentially curative stereotactic body radiation therapy (SBRT) for single or oligometastasis to the lung Oh D11, Ahn YC, Seo JM, Shin EH, Park HC, Lim do H, Pyo H.
    View PubMed
  • Indian J Exp Biol. 2012 Mar;50(3):195-200. Protective effect of triphala on radiation induced acute intestinal mucosal damage in Sprague Dawley rats Yoon WS11, Kim CY, Yang DS, Park YJ, Park W, Ahn YC, Kim SH, Kwon GY.
    View PubMed
  • Introduction of intensity modulated radiation therapy
  • Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):507-12. doi: 10.1016/j.ijrobp.2009.07.1706. Epub 2010 Jan 7. INVOLVED-LESION RADIATION THERAPY AFTER CHEMOTHERAPY IN LIMITED-STAGE HEAD-AND-NECK DIFFUSE LARGE B CELL LYMPHOMA Yu JI11, Nam H, Ahn YC, Kim WS, Park K, Kim SJ.
    View PubMed
  • Med Phys.?2010 Jun;37(6):2925-33. Comparison of film dosimetry techniques used for quality assurance of intensity modulated radiation therapy Ju SG11,?Han Y,?Kum O,?Cheong KH,?Shin EH,?Shin JS,?Kim JS,?Ahn YC.
    View PubMed
  • Clin Exp Otorhinolaryngol. 2010 Jun;3(2):96-101. doi: 10.3342/ceo.2010.3.2.96. Epub 2010 Jun 30. Treatment Results of Major Salivary Gland Cancer by Surgery with or without Postoperative Radiation Therapy Noh JM11, Ahn YC, Nam H, Park W, Baek CH, Son YI, Jeong HS.
    View PubMed
  • J Thorac Oncol. 2010 Apr;5(4):526-32. doi: 10.1097/JTO.0b013e3181cbf622. Results and Prognostic Factors of Hypofractionated Stereotactic Radiation Therapy for Primary or Metastatic Lung Cancer Kim H11, Ahn YC, Park HC, Lim do H, Nam H.
    View PubMed
  • Cancer. 2009 Aug 15;115(16):3699-708. doi: 10.1002/cncr.24414. Therapeutic Effect of Recombinant Human Epidermal Growth Factor (RhEGF) on Mucositis in Patients Undergoing Radiotherapy, With or Without Chemotherapy, for Head And Neck Cancer A Double-blind Placebo-controlled Prospective Phase 2 Multi-institutional Clinical Trial Wu HG11, Song SY, Kim YS, Oh YT, Lee CG, Keum KC, Ahn YC, Lee SW.
    View PubMed
  • Jpn J Clin Oncol. 2009 Mar;39(3):151-7. doi: 10.1093/jjco/hyn158. Epub 2009 Feb 3. Prediction of Radiation Pneumonitis Following High-dose Thoracic Radiation Therapy by 3 Gy/fraction for Non-small Cell Lung Cancer: Analysis of Clinical and Dosimetric Factors Oh D11, Ahn YC, Park HC, Lim do H, Han Y.
    View PubMed
  • Radiother Oncol. 2009 Feb;90(2):236-41. doi: 10.1016/j.radonc.2008.09.011. Epub 2008 Oct 22. Prognostic significance of anatomic subsites: Results of radiation therapy for 66 patients with localized orbital marginal zone B cell lymphoma Nam H11, Ahn YC, Kim YD, Ko Y, Kim WS.
    View PubMed
  • Med Phys. 2008 Jun;35(6):2519-27. Dosimetry in an IMRT phantom designed for a remote monitoring program Han Y11, Shin EH, Lim C, Kang SK, Park SH, Lah JE, Suh TS, Yoon M, Lee SB, Cho SH, Ibbott GS, Ju SG, Ahn YC.
    View PubMed
  • Jpn J Clin Oncol. 2008 Feb;38(2):92-8. doi: 10.1093/jjco/hym159. Epub 2008 Feb 11. High-dose thoracic radiation therapy at 3.0 Gy/fraction in inoperable stage I/II non-small cell lung cancer Kim B11, Ahn YC, Lim do H, Nam HR.
    View PubMed
  • Cancer Lett. 2007 Dec 8;258(1):90-7. Nongastric marginal zone B-cell lymphoma: A prognostic model from a retrospective multicenter study Oh SY11, Kwon HC, Kim WS, Park YH, Kim K, Kim HJ, Kwon JM, Lee J, Ko YH, Ahn YC, Oh SJ, Lee SI, Bang SM, Kim JH, Park J, Ryoo BY, Lee SS, Kim HY, Park K, Kim HJ.
    View PubMed
  • Yonsei Med J. 2007 Oct 31;48(5):827-32. Anal canal carcinoma: Experience from a single Korean institution Lee WS11, Chun HK, Lee WY, Yun SH, Yun H, Cho YB, Kang WK, Park YS, Huh SJ, Ahn YC, Park W.
    View PubMed
  • Lung Cancer. 2007 Mar;55(3):329-36. Epub 2006 Dec 8. Analyses on prognostic factors following tri-modality therapy for stage IIIa non-small cell lung cancer Kim KJ11, Ahn YC, Lim do H, Han J, Park K, Park JO, Kim K, Kim J, Shim YM.
    View PubMed
  • "Yonsei Med J. 2006 Aug 31;47(4):571-4." Lung metastasis from an immature teratoma of the nasal cavity masquerading as small cell carcinoma of the lung Kang MK11, Ahn YC, Park JO, Han J, Lee KS.
    View PubMed
  • J Korean Med Sci. 2006 Apr;21(2):229-35. Preoperative concurrent radiochemotherapy and surgery for stage IIIA non-small cell lung cancer Kang MK11, Ahn YC, Lim DH, Park K, Park JO, Shim YM, Kim J, Kim K.
    View PubMed
  • Haematologica. 2006 Mar;91(3):427-8. Epub 2006 Feb 17. The effect of pre-irradiation dose intense CHOP on anthracyline resistance in localized nasal NK/T-cell lymphoma Lee SH1, Ahn YC, Kim WS, Ko YH, Kim K, Park K.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1559-64. Real-time monitoring of a digestive tract marker to reduce adverse effects of moving organs at risk (OAR) in radiotherapy for thoracic and abdominal tumors Hashimoto T11, Shirato H, Kato M, Yamazaki K, Kurauchi N, Morikawa T, Shimizu S, Ahn YC, Akine Y, Miyasaka K.
    View PubMed
  • Yonsei Med J. 2004 Aug 31;45(4):584-90. Application of real-time tumor-tracking and gated radiotherapy system for unresectable pancreatic cancer Ahn YC11, Shimizu S, Shirato H, Hashimoto T, Osaka Y, Zhang XQ, Abe T, Hosokawa M, Miyasaka K.
    View PubMed
  • Yonsei Med J. 2004 Feb 29;45(1):100-6. High dose 3-dimensional re-irradiation for locally recurrent nasopharyngeal cancer Shin SS11, Ahn YC, Lim DH, Park W, Huh SJ.
    View PubMed
  • Med Phys.?2002 Mar;29(3):351-5. Film dosimetry for intensity modulated radiation therapy: Dosimetric evaluation Ju SG11,?Ahn YC,?Huh SJ,?Yeo IJ.
    View PubMed
  • Cancer.?2009 Aug 15;115(16):3699-708. doi: 10.1002/cncr.24414. Phase I study of weekly docetaxel and cisplatin concurrent with thoracic radiotherapy in stage III non-small-cell lung cancer Wu HG11,?Song SY,?Kim YS,?Oh YT,?Lee CG,?Keum KC,?Ahn YC,?Lee SW.
    View PubMed
  • Acta Oncol. 2001;40(5):588-92. Preoperative concurrent chemoradiotherapy for stage IIIA non-small cell lung cancer Ahn YC11, Park K, Kim DY, Kim KM, Kim J, Shim YM, Lee KS, Han J, Kim HJ, Kwon J, Lim DH, Noh YJ, Lee JE, Huh SJ.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 2000 Sep 1;48(2):501-5. Fractionated stereotactic radiation therapy for extracranial head and neck tumors Ahn YC11, Lee KC, Kim DY, Huh SJ, Yeo IH, Lim DH, Kim MK, Shin KH, Park S, Chang SH.
    View PubMed
  • Int J Radiat Oncol Biol Phys.?2000 Sep 1;48(2):541-4. Physical properties of new collimator cone system for stereotactic radiation therapy developed in Samsung Medical Center Kim DY11,?Ahn YC,?Oh DG,?Choi DR,?Ju SG,?Yeo IH,?Huh SJ.
    View PubMed
  • Head Neck. 1999 Jul;21(4):338-45. Fractionated stereotactic radiation therapy for locally recurrent nasopharynx cancer: Report of three cases Ahn YC11, Kim DY, Huh SJ, Baek CH, Park K.
    View PubMed
  • Int J Radiat Oncol Biol Phys. 1999 May 1;44(2):435-8. Design and development of new collimator cones for fractionated stereotactic radiation therapy in Samsung Medical Center Ahn YC11, Ju SG, Kim DY, Choi DR, Huh SJ, Park YH, Lim DH, Kim MK.
    View PubMed